Objectives: This article reports on the findings from applying a recently described approach to modeling health state valuation data and the impact of the respondent characteristics on health state valuations. The approach applies a nonparametric model to estimate a Bayesian six-dimensional health state short form (derived from short-form 36 health survey) health state valuation algorithm. Methods: A sample of 197 states defined by the six-dimensional health state short form (derived from short-form 36 health survey)has been valued by a representative sample of the Hong Kong general population by using standard gamble. The article reports the application of the nonparametric model and compares it to the original model estimated by using a conventional parametric random effects model. The two models are compared theoretically and in terms of empirical performance. Results: Advantages of the nonparametric model are that it can be used to predict scores in populations with different distributions of characteristics than observed in the survey sample and that it allows for the impact of respondent characteristics to vary by health state (while ensuring that full health passes through unity). The results suggest an important age effect with sex, having some effect, but the remaining covariates having no discernible effect. Conclusions: The nonparametric Bayesian model is argued to be more theoretically appropriate than previously used parametric models. Furthermore, it is more flexible to take into account the impact of covariates.
Introduction
There has been an increasing use of preference-based measures of health-related quality of life to calculate quality-adjusted lifeyears (QALYs) for use in cost-effectiveness analyses. These preference-based measures are standardized multidimensional health state classifications with preference or utility weights elicited from a sample of the general population [1] . There are currently a number of such preference-based measures, including the generic EuroQol five-dimensional (EQ-5D) questionnaire [2] , health utilities index 2 (HUI2)and 3 [3, 4] , 15D [5, 6] , Assessment of Quality of Life [7] , Quality of Well-being scale (QWB) [8] , and the six-dimensional health state short form (derived from short-form 36 health survey) (SF-6D) [9] . Condition-specific preference-based measures have also been developed [10, 11] . These measures provide empirically derived health state value that can be used to derive QALYs for use in a cost-effectiveness analysis [12] . A key problem for these measures has been the large number of unique health states that they define, such that it is not feasible to obtain direct valuations for each health state. Thus, models are constructed to predict the values for all states in a descriptive system based on direct valuations of a sample of states.
Health state values present a significant challenge for conventional statistical modeling procedures due to their nature, namely, skewed, truncated, noncontinuous, and hierarchical [9] . Attempts to statistically model these data have met with some success in the SF-6D [9] , EQ-5D questionnaire [13] , and HUI2 [14] . For these instruments, however, there are concerns with the size of the prediction errors, and for the SF-6D, there is a problem of nonmonotonicity (where some better states are assigned a lower value than worse states) and an apparent systematic pattern in the prediction errors (involving overprediction of the value of poor health states and underprediction of the value of good health states). Furthermore, these methods are limited in the way they are able to model the impact of covariates on health state values. The main limitation is that covariates are modeled only in terms of their impact on the intercept. It is worth noting that this is not a weakness of parametric methods per se because it is perfectly reasonable to interact covariates with the levels of the SF-6D, rather the parametric methods that have been used in articles in this specific area. These results in the intercept deviating from unity, which contravenes the requirement that full health equals 1 on the conventional full health-death scale used to estimate QALYs. It also means that the impact of a covariate is assumed to be the same regardless of the state; so, for example, the impact is the same regardless of the severity of the state. This is an unrealistic assumption.
Kharroubi et al. [15] reported an alternative, nonparametric Bayesian method for modeling health state preference data. Their method describes the intrinsic characteristics of individual health state valuation data in a way that is argued to be more theoretically appropriate than previously used parametric models. Furthermore, this method is more flexible to take into account the impact of covariates, which 1) enables the estimation of the impact of covariates on the state as a whole and not just the intercept term, and 2) allows for the fact that each individual values several states, by incorporating individual random effects that can be linked to covariates and retain the feature that perfect health should have a value of 1. Kharroubi et al. [16] reported the findings from applying this method to modeling SF-6D UK health state valuation data, and Kharroubi et al. [17] extended the method to address covariates in the SF-6D UK data. Kharroubi and McCabe [18] have also applied it to the HUI2 UK valuation data. In this article, we report the application of this method to the SF-6D HK valuation data reported by McGhee et al. [19] and compare the results with the conventional random-effect regression model. It is worth mentioning that the method presented in this article is a replication of the method used to model the UK data nonparametrically (the Kharroubi et al. [15] [16] [17] articles describe this at length). Thus, while it does not provide new methodological advances, it further emphasizes the point made in the Kharroubi et al. articles [15] [16] [17] that the nonparametric approach performs well.
The second section of this article briefly describes the SF-6D HK valuation study and the data used in this article. A detailed description has been reported elsewhere [19] . The third section sets out the parametric and nonparametric approaches for health state valuations. The next section presents the results from each approach and compares the models in terms of their ability to predict actual values and to estimate the impact of covariates. Finally, we conclude with a discussion of the results and their implication for future use of the SF-6D and modeling work in this field.
The SF-6D HK Data Set
The SF-6D, derived from the SF-36, is a generic measure of health [20] . It is composed of six multilevel dimensions of health: physical functioning, role limitation, social functioning, bodily pain, mental health, and vitality. It was constructed from a sample of 11 items selected from the SF-36 to minimize the loss of descriptive information [9] . The six dimensions have between four and six levels. An SF-6D health state is defined by selecting one statement from each dimension, starting with physical functioning and ending with vitality. Level 1 in each dimension represents no loss of health or functioning in that dimension, so that state 111111 denotes perfect health. The worst possible state is 645655, known as "the pits." A total of 18,000 health states can be defined in this way.
The Chinese Hong Kong (HK) version of the SF-6D was derived from the English UK version by forward-backward translations ( Table 1) . The SF-6D HK was field tested in a pilot study and showed that the valuation method was feasible and the resulting data were reliable and fitted quite well in an econometric model [21] . A selection of 197 (196 states plus perfect health) states defined by the SF-6D have been valued by a representative sample of the HK general population by using the standard gamble (SG) technique [19] . The 196 health states were selected in two ways. One part of the sample was identified by using an orthogonal design (by applying the Orthoplan procedure of SPSS) that generates 49 health states to estimate an additive model. A further 147 states were selected by using a stratified random sampling method to ensure a balance of mild, moderate, and severe states. All states were checked to ensure that they described credible combinations of dimension levels [19] .
The face-to-face interview procedure was modeled on that used in the UK study [9] , which was based on methodology developed at McMaster University, Canada. Each participant was asked to rank a set of 10 health state cards and then rate them by using a visual analogue scale of 0 to 100 points, where the end points were the best and the worst imaginable health states. This ranking and rating exercise was followed by the SG procedure [19] . While evaluating each of the seven health states, the participants were asked to choose between an intervention (choice A) involving uncertain health outcomes and a certain health state defined by the SF-6D HK states (choice B). There were two possible health outcomes in choice A: the best health state (H) if the treatment was successful and the worst health state (K) if the treatment failed. The seven health states were placed in choice B one by one as the certain health state under valuation. Once the seven states had been valued, an eighth choice was presented. The reference state in choice A was represented by the state judged by this individual as the poorest, either K or L. The other one of states K or L then became choice B. This enabled valuation of K against L. (See McGhee et al. [19] for more details.)
Choice A, the intervention, involved the best health outcome with probability P and the worst health outcome with probability 1 -P. The probability of the outcomes was varied until the respondent was indifferent between choosing A or B. At that point, the preference-based utility value of the health state in choice B was reached and was reflected by the probabilities of the outcomes. For example, if the respondent was indifferent when the probability of the best outcome was 80% and the worst was 20%, then the utility value was taken as 0.80. Probabilities in terms of percentages for the certain/uncertain outcomes were varied in the following order: 0/100, 90/10, 10/90, 80/20, 20/80, 70/ 30, 30/70, 60/40, 40/60, and 50/50. This is called the "ping-pong method" because it alternates between a "good" state and a "poor" state. Respondents were asked to give reasons if they had chosen choice B for 100/0 and choice A for 0/100 because these were considered as illogical answers. See McGhee et al. [19] for more details.
The respondent was asked for further information on marital status, number of children, employment, place of birth, number of family members, type of housing, household income, medical benefits, and health-related questions to control for these in the analysis [19] . The value for each health state was then transformed to a scale, with 1 as perfect health and 0 equivalent to death. This adjusted SG value forms the dependent variable (y) in the models discussed below.
Of the 641 participants in the face-to-face interviews, 29 (4.5%) were excluded from the analysis because they failed to appropriately value the pits state and it was therefore not possible to generate an adjusted SG value for them. Most of these participants ( 
observations lay between 0.9 and 1.0. More than half of the respondents (354 of 582, 61%) valued the pits state better than death. The details of the valuations for each of the 197 SF-6D HK health states are given in McGhee et al. [19] .
Modeling
The generic SF-6D descriptive system describes 18,000 possible health states, and the empirical survey could obtain valuations for only a small subset. The aim of modeling is to estimate health state utility values for all states. The utility associated with a health state is assumed to be a function of that state; hence, by estimating a relationship between the descriptive system and the observed values, we can infer values for all states. Valuation surveys generate data with a complex structure creating a number of problems for estimation, and a variety of techniques have been used to deal with these problems, one of which is between respondent variations. In the main, these have used parametric relationships with particular assumptions about functional form, but here we contrast this conventional parametric approach reported by McGhee et al. [19] with a more flexible Bayesian nonparametric model.
A general model for health state valuations can be described by (see Kharroubi et al. [15] and McGhee et al. [19] )
where for i ¼ 1, 2, …, n j and j ¼ 1, 2, …, m, x ij is the ith health state valued by respondent j and the dependent variable y ij is the adjusted SG score given by respondent j for that health state. The general model has two sets of independent, zero-mean, random effect terms: ε ij is a random error term associated with each observation, and α j is a term to allow for individual characteristics of respondent j. The interpretation of f ðx ij ,α j Þ is as the true indifference SG value that respondent j has for health state x ij . The objective is to obtain a health state utility measure for the population as a whole, and this is generally taken to be the mean of the respondent-level health state utilities across the population. To account for different populations, it is possible to model α j in terms of respondent-level covariates such as age, gender, or socioeconomic factors. Note. The SF-36 items used to construct the SF-6D are as follows: physical functioning items 1, 2, and 10; role limitation due to physical problems item 3; role limitation due to emotional problems item 2; social functioning item 2; both bodily pain items; mental health items 1 (alternate version) and 4; and vitality item 2. SF-6D, six-dimensional health state short form (derived from SF-36); SF-36, short-form 36 health survey.
The Parametric Approach
McGhee et al. [19] specify the following model for respondent j's health state utility:
where μ and h denote unknown parameters and Iðx ij Þ is a vector of dummy explanatory variables. In the simplest, no-interactions, case of this model, Iðx ij Þ is a vector of terms I δλ ðx ij Þ for each level λ > 1 of dimension δ of the SF-6D. For example, I 32 ðx ij Þ denotes dimension δ ¼ 3 (social functioning), level λ ¼ 2 (health limits social activities a little of the time). For any given health state x ij , I δλ ðx ij Þ is defined as follows:
In all, there are 25 of these terms, with level λ ¼ 1 acting as a baseline for each dimension. Hence, the intercept parameter μ represents the health state utility value for state (111111), and summing the coefficients θ δλ of the "on" dummies and adding this to the intercept derives the value of any other state.
More generally, Iðx ij Þ can include additional dummy variables to account for interactions between the levels of different dimensions, and the model selected by McGhee et al. [19] included one such term, MOST, which takes the value of 1 if any dimension in the health state is at one of the most severe levels, and 0 otherwise (Most severe is defined as levels 4-6 for physical functioning, 3 and 4 for role limitation, 4 and 5 for social functioning, mental health, and vitality, and 5 and 6 for pain.)
Estimation of this random effects model is via generalized least squares or maximum likelihood. Because α j has 0 mean, the population health state utility for state x in this model is simply μ^þĥ′IðxÞ.
The Nonparametric Approach
The models used in all previous analyses have, like (2), been parametric. They have therefore imposed a particular form on the utility function. Kharroubi et al. [15] proposed a nonparametric approach that allows the function to take any form at all, using Bayesian hierarchical modeling. In this section, we review some of the methods and results in Kharroubi et al. [15] . This is necessary to ease the development in the subsequent sections and to facilitate comparison with parametric results in the article.
Kharroubi et al. [15] build a new Bayesian statistical nonparametric model to describe the intrinsic characteristics of individual health state valuation data that they argued is more theoretically appropriate than previous parametric models. For respondent j, the health state utility of state
Note that the individual respondent term α j enters multiplicatively rather than additively as in (2) . The term u(x) is the median health state utility of health state x. (In the Kharroubi et al. [15] model, the distribution of α j is normal, and so it has 0 median as well as 0 mean, and the median of expðα j Þ is therefore 1.) It is treated as an unknown function, and in Bayesian framework, it therefore becomes a random variable. The prior distribution for
Note that x is a vector comprising discrete levels on each of the six health dimensions. Note also that the mean function of (4) represents a belief that the utility will be approximately linear and additive in the different dimensions, but whereas (2) imposes this linearity and additively as a strict assumption about the utility function, our model simply expresses it as a prior expectation. The hierarchical model says that the function is more likely to be close to the linear, additive form than to be very different from that form, but this prior distribution will be modified by the data. It will thereby adapt to whatever functional form is suggested by the data. If the data are particularly strong, they will overrule the prior expectation. In practice, the data will generally be less strong, in which case the prior model will smooth the empirical relationship suggested by the data toward the form suggested by the mean function of (4). (See Kharroubi et al. [15] for more details.) Furthermore, the values of uðxÞ and uðx′Þ for two different states x and x′ have a correlation cðx,x′Þ that decreases as the distance between x and x′ increases. This is defined as
where for d ¼ 1, 2, …, 6, x d and x d 0 are the levels of dimension d in the health states x and x′, respectively, and b d is a roughness parameter in dimension d. As discussed in [15] , this function plays a key role in determining how closely the utility function is constrained by the prior distribution toward the parametric form of the mean function of (4). Many other choices might be made for this covariance function, but the resulting estimates are not generally sensitive to the form of the function. The roughness parameters control how closely the true utility function is expected to adhere to a linear form in each dimension. We adopt default values of these parameters, as discussed in [15] , that create a substantial correlation between neighboring health states to represent the local smoothness and linearity of the utility function but the correlation falls away rapidly to allow the general shape of the function to respond to the data. Note that the mean health state utility in (3) is
where α is the mean value of expðαÞ over the whole population. This will not in general be 1, and so the population (mean) health state utility is not the same as the median health state utility u(x). More details of the nonparametric modeling and evaluation of α are given in Kharroubi et al. [15] . For this article, the variable α j is allowed to vary because this captures the impact of respondent characteristics. Suppose that t j is the vector of covariates for respondent j. We then propose
where θ is the vector of coefficients for the covariates. Note here that t's are centered to ensure that they have 0 means, and hence that the value of expðαÞ for a typical person is 1. The models and the programs to undertake the Bayesian approach were written in Matlab and are available on request.
Comparison of Models
The two models cannot be compared in terms of a simple table of coefficients as in McGhee et al. [19] because the nonparametric model produces in effect a separate parameter for all the 18,000 health states. Given that the overall aim is to predict health state valuations, the best way to compare these models is via their predictive ability.
Results
The models are compared in terms of their predictive ability in Figures 1 and 2 [9] and McGhee et al. [19] . This is better on statistical grounds and
easier to interpret). Figure 1 presents the resulting predicted mean health state valuations (line marked with squares) for the parametric model (2), along with actual mean health state valuations (line marked with diamonds). The line marked with triangles represents the errors obtained by the difference between the two valuations. Figure 2 presents the corresponding plots for the nonparametric model. The plots suggest that the parametric model overpredicts the value of the better states, whereas this does not seem to have been a problem for the nonparametric model. The plots also suggest that the variations of the predictions are larger, and so a nonsteady trend of the difference (line marked with triangles) for the parametric model. This provides an initial indication that the nonparametric model is less prone to systematic bias.
To better quantify the gains in terms of bias/precision, Figure 3 shows the Bland-Altman agreement plot [22] , where the difference scores of the predicted and actual mean health state valuations are plotted against the average scores of the two valuations for the parametric model. The solid line represents the average bias (or the average of the differences), and the dotted lines are the 95% limits of agreement. Figure 4 presents the corresponding agreement plot for the nonparametric model. The presentation of the 95% limits of agreement is for visual judgment of how well the two valuations agree. The smaller the range between these two limits, the better the agreement is. The plots suggest that the nonparametric model shows good agreement as the width of the 95% limits of agreement is 0.197, which is narrower than that of the parametric model with a width of 0.324. Although the average bias for both models is close to 0, with values of 0.011 for the nonparametric model and -0.020 for the parametric model, the SD of the differences for the nonparametric model is rather smaller than for the parametric model, with values of 0.050 and 0.0825, respectively. This justifies the large variations of the differences in Figure 3 . In contrast, it is Figure 4 that the nonparametric model differences are well validated. Table 2 reports the observed sample mean health state utility and the predicted mean and SD for the population mean health state utility from both the nonparametric and parametric models. Across the 197 states that were used in the study, the predictive performance of the nonparametric model is better than that of the parametric model overall, with a root mean square error (RMSE) of 0.051 for the nonparametric model and 0.085 for the parametric model.
For both models, no state is estimated as being worse than death. Important differences, however, can be seen between the models from Table 2 . The parametric model estimates the health state utility for the pits state to be 0.169, even though the observed average for this state is 0.067, whereas the nonparametric model achieves a value of 0.098. At the other end of the scale, the parametric model is more prone to overpredict milder states. It can also be seen that the SDs of the predictions are larger for the parametric model. The parametric SDs are larger because they are based on the assumption that the preference function is additive in the various factors, apart from the MOST term. The posterior SDs are smaller primarily because it is a model that admits uncertainty about the shape of the health state utility function.
The overall impact of this can be seen from the plots in Figures  5 and 6 , which show, respectively, the predicted values using the parametric and nonparametric models against observed mean values of the 197 health states, with perfect prediction indicated by a 45-degree line of unity (solid line). Figures 5 and 6 show that the magnitude of the differences in predicted and observed mean valuations increased with decreasing valuations of these health states. The magnitude of differences, however, is more obvious in Figure 5 for the parametric model. Furthermore, Figure 6 shows that the predicted mean health state values for the nonparametric model form a scatter around the line with no strong pattern, while Figure 5 shows a larger scatter and the points deviate systematically from the 45-degree theoretical line; therefore, the parametric model is not well validated by its predictive performance. In contrast, it is apparent from Figure 6 that the nonparametric model predictions are well validated.
As always, it is important to check the validity of the assumed models. Figure 7 plots a histogram of standardized residuals across all 4596 health state valuations for the parametric model, and Figure 8 plots the corresponding standardized residuals for the nonparametric model. According to these models, we would expect these to be approximately N (0, 1). Figures 7 and 8 broadly support this, although there is some evidence of skewness, which is more obvious in Figure 7 . This is not surprising, given the negative skewness in the original SG data at the individual level. The degree of skewness, however, is probably not high enough to invalidate the analyses in both models, which assume normally distributed errors.
A better test of the validity of the model is to investigate its ability to predict the values for states that have not been used in the estimation. Data relating to 30 selected health states were removed randomly from the estimation data, and the models fitted on data for the remaining 167 states. Table 3 presents the true sample means for the 30 omitted states, together with their predicted mean and SD values from the parametric and nonparametric models estimated on the reduced data set. The predictive performance of the nonparametric model is better than that of the parametric model overall, with RMSEs of 0.056 and 0.071, respectively. It can be seen that the nonparametric model predicts the omitted data quite well, and better than the parametric model. It is to be noted that the predictive SDs here for both models are larger than those in Table 2 , because the model in Table 2 is predicting the data on which it was estimated, whereas the model in Table 3 is predicting out of sample data. The parametric standard errors are larger than the nonparametric ones, primarily because the nonparametric analysis is able to make use of other evaluations by the same respondents to estimate their individual random effects, which the frequentist analysis cannot do. Figures 9 and 10 show the Q-Q plots of standardized predictive errors for the 30 health states sample means, for the parametric and nonparametric models, respectively. In each figure, the straight line corresponds to a reference line passing through the first and third quartiles, which is helpful for judging whether the points are linear. Figure 9 suggests that the parametric model is not well validated by its predictive performance. In contrast, it is apparent from Figure 10 that the nonparametric model predictions are well validated. Note that although these results are for omitting one set of 30 health states chosen at random, we have obtained almost identical results across five replicates.
To capture the impact of the respondent characteristics, Figure 11 shows the histograms of the conditional posterior distribution functions of the covariates' sex and age. These results indicate that age and sex have strong effects because they are not centered on 0. To demonstrate the impact of Table 2 with and without adjusting for covariates. The actual HK age and sex distributions were taken from the HK census of 2006 [23] . These results show that the largest differences between health state values are for the most severe SF-6D health state. Mean health state values for the pits state are 0.054 and 0.098 with and without adjusting for age and sex, respectively, with difference of 0.044. Note that the observed average for this state is 0.067. This difference declines as states become milder. This suggests that the magnitude of the gain of moving from a severe to mild state will be smaller for older age groups. We consider this finding in more detail in the Discussion section.
Discussion
In this article, we have applied nonparametric Bayesian methods to the existing HK SF-6D valuation data in an attempt to overcome some of the limitations observed when a parametric approach has been taken. The method is a replication of the method used to model the UK data nonparametrically (the Kharroubi et al. [15] [16] [17] articles describe this at length). Thus, while it does not provide new methodological advances, it further emphasizes the point made in the Kharroubi et al. articles [15] [16] [17] that the nonparametric approach performs well. 
We have presented two sets of analyses; the first has compared a Bayesian main-effects model with a previously published conventional main-effects model [19] . The second has used the flexibility of the nonparametric Bayesian method to examine the impact of covariates on health state values.
The nonparametric model represents the following important characteristics of the data more accurately than does the conventional parametric random-effects model: the nature of individual respondent effects, repeated measurements from each individual, and the skew distribution of individual valuations of a given state.
The model also allows for respondent-level covariates to enter in a natural way as predictors of individual respondent effects.
These theoretical advantages of the nonparametric model are reflected in the appreciable improvements to the predictive ability as reflected in better RMSE and the standardized predictive errors in the out of sample validation. The extra flexibility of the nonparametric model and improved performance, however, come at the expense of computational complexity, and specialist software is needed to estimate the preference function (see Kharroubi et al. [15] for details). Furthermore, the resulting estimated preference function cannot be defined by a simple table of coefficients as in Brazier et al. [9] and McGhee et al. [19] articles, because in effect there is a parameter for all the 18,000 health states. There is a loss of transparency, but in practice it is straightforward to obtain utilities for any required health states through software available from the author on request.
As reported earlier, the analysis of covariates showed that age and sex are important determinant of health state values. This impact of age and sex on health state values is also shown in Figure 12 , where the posterior mean health state values (for both males and females) have been drawn against age for three health states: the pits or the worst state (645655), a moderate state (423435), and a mild state (211111). For the pits state, the curve (for both males and females) follows a clear quadratic, with the value increasing until 45 to 50 years of age and then it starts to fall off gradually for the next 20 years and then more sharply. The other two states follow the same inverted "U," but their shape is less dramatic, particularly for the mildest state. The largest difference was for the pits state of 0.2825 and 0.3061 for males and females, respectively, but this difference was less for milder states. We also see from Figure 12 that the female line is below the male line for the three health states. The difference, however, between both males and females follows a clear decline. For the pits state, the difference of 0.075 was big on average. This difference declines as states become milder (423435) and almost negligible for the mildest state (211111). This result indicates that the impact of age and sex depends crucially on the severity of the states.
There are important similarities to the findings of another large-scale survey analyzed by using multivariate techniques, the UK time trade-off (TTO) valuation of the EQ-5D questionnaire [24] . This study found age, marital status, and sex to be significant variables, with the same direction of impact, and age even had an inverted U shape, though the maximum was at 45. There was, however, a concern in the EQ-5D questionnaire study that the age effect might have been artefactual because a large proportion of older respondents did not believe that the TTO question for states worse than being dead was credible [25] . The variant of TTO used in that survey asked respondents to consider living in the state they regarded as worse than being dead for x years followed by 10 -x years in full health. Many older people did not believe that they would live for 10 years and so perhaps gave a lower value for x. The SG question here did not suffer from this artefact and so provides further support that there does seem to be a genuine age effect that follows this inverted U shape. In addition, our modeling implies that this effect is not the same across states, but is steepest for the most severe states and becomes flatter as states become milder. Analyses by Kharroubi et al. [17] of the SF-6D data and by Kharroubi and McCabe [18] of the HUI2 data have also found this type of relationship. The findings about age may also reflect an adaptation effect or at least the consequences of experiencing many of the states in the past or the context of mixing with older and so less on average healthy individuals. It also may be to do with a person's changing living circumstances, with respondents in middle age being less willing to risk their life because of having greater 1 6 ( 2 0 1 3 ) 1 0 3 2 -1 0 4 5 responsibilities than the young and old. The underlying reasons for this finding, however, are not fully understood [26] . The reasons for sex are also unclear, though the finding for sex is consistent with previous work [24] .
The observed relationship between age and utility may have implications for our understanding of the difference between patient and general population health state values. Because ill health is positively correlated with age, ceteris paribus, patients' values are likely to be lower than general population values. Thus, the degree of adaptation that leads to the observation that patients value health states more highly than the general population may be larger than currently thought. At a minimum, future analyses of comparative data should control for age when estimating the scale of divergence between patient and general population values.
This article does not address the policy implications of the differences found here. For policymakers wishing to use different tariffs of values by age group or some other background characteristics, the nonparametric Bayesian method provides a more appropriate way to do this than do traditional modeling techniques. Most policymakers around the world want to use health states valued by a representative sample of the general population [27] . For such a policy, this article presents a method for adjusting for differences in a survey sample from the general population.
